Clinical Trials Logo

Clinical Trial Summary

Investigator is studying the effects of Lidocaine and Adrenaline Soaked Gauze vs Normal Saline Soaked Gauze at Skin Graft Donor Site of Thigh. Haemostatic effect, epithelization and post operative pain will be assessed on follow up.


Clinical Trial Description

After admission participants will be randomized either to be in Group A or Group B. Closed envelop technique will be used for random assignment of the patients. Group A will be receiving 2% lidocaine and 1:100,000 adrenaline soaked gauze while group B will be given only normal saline soaked gauze at donor-site for ten minutes. The primary end point of study is intraoperative bleeding. The secondary end points of study include no. of dressings required in first 24 hours after surgery, donor site epithelization at 14th post-operative day, post-operative pain in first 24 hours after surgery along with systemic analgesia requirement after surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04344483
Study type Interventional
Source Dow University of Health Sciences
Contact
Status Completed
Phase N/A
Start date December 10, 2019
Completion date June 10, 2020

See also
  Status Clinical Trial Phase
Completed NCT03632031 - Treatment of Wounds Using Oasis® ECM
Completed NCT03230175 - Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01) Phase 2
Completed NCT04483934 - Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts Phase 1/Phase 2
Terminated NCT04134143 - Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers Phase 1
Recruiting NCT04450693 - Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II) Phase 3
Not yet recruiting NCT06327113 - Antibiotic Tumescent For Chronic Wounds Phase 2
Not yet recruiting NCT03049670 - The Use of Klorsept Solution for Debriding Infected Wounds: is it Effective and Safe? Prospective Observational Study N/A
Not yet recruiting NCT05766982 - Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP) N/A
Recruiting NCT05921292 - Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies Phase 1
Active, not recruiting NCT04176120 - Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU) Phase 3
Completed NCT02657876 - ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers Phase 1
Not yet recruiting NCT06109844 - FORCEREPAIR - A Wound Exudate Investigation
Terminated NCT04240574 - Debritom - Micro Water Jet Technology and Wound Healing N/A
Completed NCT05154838 - Development of Volatile Organic Compounds (VOC) Analysis as a Potential Diagnostic for Infected and Non-Healing Wounds
Not yet recruiting NCT03732365 - Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds Phase 2
Not yet recruiting NCT05251480 - Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People N/A
Recruiting NCT05739149 - A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers N/A
Completed NCT03863054 - An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (NATROX™) on the Rates of Healing of Chronic Diabetic Foot Ulcers
Recruiting NCT06028386 - Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers N/A
Enrolling by invitation NCT06328010 - An Observational Clinical Registry to Collect Safety and Efficacy Data on Wound Care in Medical Centers